Cargando…
Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach
Steric blocking antisense oligonucleotides (ASO) are promising tools for splice modulation such as exon-skipping, although their therapeutic effect may be compromised by insufficient delivery. To address this issue, we investigated the synthesis of a 20-mer 2′-OMe PS oligonucleotide conjugated at 3′...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707236/ https://www.ncbi.nlm.nih.gov/pubmed/34946743 http://dx.doi.org/10.3390/molecules26247662 |
_version_ | 1784622387604488192 |
---|---|
author | Marchesi, Elena Bovolenta, Matteo Preti, Lorenzo Capobianco, Massimo L. Mamchaoui, Kamel Bertoldo, Monica Perrone, Daniela |
author_facet | Marchesi, Elena Bovolenta, Matteo Preti, Lorenzo Capobianco, Massimo L. Mamchaoui, Kamel Bertoldo, Monica Perrone, Daniela |
author_sort | Marchesi, Elena |
collection | PubMed |
description | Steric blocking antisense oligonucleotides (ASO) are promising tools for splice modulation such as exon-skipping, although their therapeutic effect may be compromised by insufficient delivery. To address this issue, we investigated the synthesis of a 20-mer 2′-OMe PS oligonucleotide conjugated at 3′-end with ursodeoxycholic acid (UDCA) involved in the targeting of human DMD exon 51, by exploiting both a pre-synthetic and a solution phase approach. The two approaches have been compared. Both strategies successfully provided the desired ASO 51 3′-UDC in good yield and purity. It should be pointed out that the pre-synthetic approach insured better yields and proved to be more cost-effective. The exon skipping efficiency of the conjugated oligonucleotide was evaluated in myogenic cell lines and compared to that of unconjugated one: a better performance was determined for ASO 51 3′-UDC with an average 9.5-fold increase with respect to ASO 51. |
format | Online Article Text |
id | pubmed-8707236 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87072362021-12-25 Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach Marchesi, Elena Bovolenta, Matteo Preti, Lorenzo Capobianco, Massimo L. Mamchaoui, Kamel Bertoldo, Monica Perrone, Daniela Molecules Article Steric blocking antisense oligonucleotides (ASO) are promising tools for splice modulation such as exon-skipping, although their therapeutic effect may be compromised by insufficient delivery. To address this issue, we investigated the synthesis of a 20-mer 2′-OMe PS oligonucleotide conjugated at 3′-end with ursodeoxycholic acid (UDCA) involved in the targeting of human DMD exon 51, by exploiting both a pre-synthetic and a solution phase approach. The two approaches have been compared. Both strategies successfully provided the desired ASO 51 3′-UDC in good yield and purity. It should be pointed out that the pre-synthetic approach insured better yields and proved to be more cost-effective. The exon skipping efficiency of the conjugated oligonucleotide was evaluated in myogenic cell lines and compared to that of unconjugated one: a better performance was determined for ASO 51 3′-UDC with an average 9.5-fold increase with respect to ASO 51. MDPI 2021-12-17 /pmc/articles/PMC8707236/ /pubmed/34946743 http://dx.doi.org/10.3390/molecules26247662 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Marchesi, Elena Bovolenta, Matteo Preti, Lorenzo Capobianco, Massimo L. Mamchaoui, Kamel Bertoldo, Monica Perrone, Daniela Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach |
title | Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach |
title_full | Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach |
title_fullStr | Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach |
title_full_unstemmed | Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach |
title_short | Synthesis and Exon-Skipping Properties of a 3′-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting DMD Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach |
title_sort | synthesis and exon-skipping properties of a 3′-ursodeoxycholic acid-conjugated oligonucleotide targeting dmd pre-mrna: pre-synthetic versus post-synthetic approach |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707236/ https://www.ncbi.nlm.nih.gov/pubmed/34946743 http://dx.doi.org/10.3390/molecules26247662 |
work_keys_str_mv | AT marchesielena synthesisandexonskippingpropertiesofa3ursodeoxycholicacidconjugatedoligonucleotidetargetingdmdpremrnapresyntheticversuspostsyntheticapproach AT bovolentamatteo synthesisandexonskippingpropertiesofa3ursodeoxycholicacidconjugatedoligonucleotidetargetingdmdpremrnapresyntheticversuspostsyntheticapproach AT pretilorenzo synthesisandexonskippingpropertiesofa3ursodeoxycholicacidconjugatedoligonucleotidetargetingdmdpremrnapresyntheticversuspostsyntheticapproach AT capobiancomassimol synthesisandexonskippingpropertiesofa3ursodeoxycholicacidconjugatedoligonucleotidetargetingdmdpremrnapresyntheticversuspostsyntheticapproach AT mamchaouikamel synthesisandexonskippingpropertiesofa3ursodeoxycholicacidconjugatedoligonucleotidetargetingdmdpremrnapresyntheticversuspostsyntheticapproach AT bertoldomonica synthesisandexonskippingpropertiesofa3ursodeoxycholicacidconjugatedoligonucleotidetargetingdmdpremrnapresyntheticversuspostsyntheticapproach AT perronedaniela synthesisandexonskippingpropertiesofa3ursodeoxycholicacidconjugatedoligonucleotidetargetingdmdpremrnapresyntheticversuspostsyntheticapproach |